Troels Johansen
Rehaler receives 2.18 million DKK from the Danish Innovation Fund for new migraine treatment
The Innovation Fund has awarded Rehaler an Innobooster grant for the large scale clinical trial aiming to validate the effect of the...
Investor news
Troels Johansen
- Dec 1, 2021
Rehaler closes financing round and strengthens Board of Directors
Rehaler closes financing round of 6.1m DKK and strengthens Board of Directors with four experienced profiles.